Johnson & Johnson is a global healthcare company committed to improving the health and well-being of people worldwide. Its mission is to blend heart, science, and ingenuity to profoundly change the trajectory of health for humanity. The company operates through three main segments: Pharmaceuticals, Medical Devices, and Consumer Health Products. Johnson & Johnson employs a strategy focused on innovation, sustainability, and collaboration, aiming to deliver high-quality products and solutions that address pressing health challenges while fostering trust and transparency with consumers and healthcare professionals.

JOHNSON & JOHNSON

Johnson & Johnson (NYSE: JNJ) continues to demonstrate resilience in the pharmaceutical sector, bolstered by its solid financial profile, which boasts $20 billion in annual free cash flow and a coveted AAA bond rating. The company has maintained a notable 3.1% dividend yield, with an impressive history of 62 consecutive...

Johnson & Johnson Reports Strong Earnings Amid Challenges in Vaccine Development and Increased Competition for Stelara